摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-methylphenoxy)-N-(tricyclo[3.3.1.1~3,7~]dec-1-yl)acetamide

中文名称
——
中文别名
——
英文名称
2-(2-methylphenoxy)-N-(tricyclo[3.3.1.1~3,7~]dec-1-yl)acetamide
英文别名
N-(1-adamantyl)-2-(2-methylphenoxy)acetamide
2-(2-methylphenoxy)-N-(tricyclo[3.3.1.1~3,7~]dec-1-yl)acetamide化学式
CAS
——
化学式
C19H25NO2
mdl
——
分子量
299.4
InChiKey
RMWFBZRUWJDICZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS
    申请人:JANSSEN PHARMACEUTICA N.V.
    公开号:EP1796657A2
    公开(公告)日:2007-06-20
  • N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors
    申请人:Jaroskova Libuse
    公开号:US20080064693A1
    公开(公告)日:2008-03-13
    The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1, 2, 3, or 4; Z represents O, S, NR 6 , SO or SO 2 ; R 1 represent hydrogen, cyano, hydroxy, or C 1-4 alkyl optionally substituted with halo, R 2 represents hydrogen, C 1-4 alkyl, or C 1-4 alkyloxy-; R 3 represents hydrogen, C 1-4 alkyl, C 1-4 alkyloxy- or R 3 combined with R 2 form together a divalent radical selected from the group consisting of —O—CH 2 — (a), —NR 7 —CH 2 — (b), —(CR 8 R 9 ) m — (c) and —CR 10 ═ (d) wherein m represents 1 or 2 and R 7 , R 8 , R 9 and R 10 are each independently selected from hydrogen or C 1-4 alkyl; R 4 represents hydrogen, halo, hydroxy, cyano, amino, NR 11 R 12 , C 1-4 alkyloxy-optionally substituted with one or where possible two or three substituents selected from hydroxy and halo or R 4 represents C 1-4 alkyl optionally substituted with one or where possible two or three substituents selected from hydroxy and halo; R 5 represents hydrogen, halo, cyano, amino, phenyl, hydroxy, C 1-4 alkyloxycarbonyl, hydroxycarbonyl, NR 13 R 14 or C 1-4 alkyl substituted with one or more substituents selected from hydroxycarbonyl, phenyl, C 1-4 alkyloxy or NR 15 R 16 ; R 6 represents hydrogen; R 11 and R 12 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-; R 13 and R 14 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-; R 15 and R 16 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-; R 17 and R 18 each independently represent hydrogen, C 1-4 alkyl or C 1-4 alkylcarbonyl-.
  • US8344181B2
    申请人:——
    公开号:US8344181B2
    公开(公告)日:2013-01-01
  • [EN] N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS<br/>[FR] DERIVES D'ACETAMIDES N-2 ADAMANTANYL-2-PHENOXY UTILISES EN TANT QU'INHIBITEURS DE LA DESHYDROGENASE 11-BETA HYDROXYSTEROIDE
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2006024627A2
    公开(公告)日:2006-03-09
    The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1, 2, 3, or 4; Z represents O, S, NR6, SO or SO2; R1 represent hydrogen, cyano, hydroxy, or C1-4alkyl optionally substituted with halo, R2 represents hydrogen, C1-4alkyl, or C1-4alkyloxy-; R3 represents hydrogen, C1-4alkyl, C1-4alkyloxy- or R3 combined with R2 form together a divalent radical selected from the group consisting of -O-CH2- (a), -NR7-CH2- (b), -(CR8R9)m- (c) and -CR10= (d) wherein m represents 1 or 2 and R7, R8, R9 and R10 are each independently selected from hydrogen or C1-4alkyl; R4 represents hydrogen, halo, hydroxy, cyano, amino, NR11R12, C1-4alkyloxy- optionally substituted with one or where possible two or three substituents selected from hydroxy and halo or R4 represents C1-4alkyl optionally substituted with one or where possible two or three substituents selected from hydroxy and halo; R5 represents hydrogen, halo, cyano, amino, phenyl, hydroxy, C1-4alkyloxycarbonyl, hydroxycarbonyl, NR13R14 or C1-4alkyl substituted with one or more substituents selected from hydroxycarbonyl, phenyl, C1-4alkyloxy or NR15R16; R6 represents hydrogen; R11 and R12 each independently represent hydrogen, C1-4 alkyl or C1-4 alkylcarbonyl-; R13 and R14 each independently represent hydrogen, C1-4 alkyl or C1-4 alkylcarbonyl-; R15 and R16 each independently represent hydrogen, C1-4 alkyl or C1-4 alkylcarbonyl-; R17 and R18 each independently represent hydrogen, C1-4 alkyl or C1-4 alkylcarbonyl-.
查看更多